In the decade-lengthy fight to deal with CRISPR, the super-tool for altering DNA, it’s been normal for lawyers to try to clearurn patents held by competitors. But now, in a surpelevate twist, the team that obtained the Nobel Prize in chemistry for broadening CRISPR is asking to abort two of their own seminal patents, MIT Technology Resee has lobtained.
The seek to retreat the pair of European patents, by lawyers for Emmanuelle Charpentier and Jennifer Doudna, comes after a damaging August opinion from a European technical requests board, which ruled that the duo’s earliest patent filing didn’t elucidate CRISPR well enough for other scientists to engage it and doesn’t count as a proper originateion.
The decision could have beginant ramifications think abouting who gets to assemble the lucrative licensing fees on using the technology.Read the brimming story.
— Antonio Regalado
A minuscule recent uncover-source AI model carry outs as well as mighty huge ones
What’s recent: The Allen Institute for Artificial Intelligence (Ai2), a research nonprofit, is releasing a family of uncover-source multimodal language models, called Molmo, that it says carry out as well as top proprietary models from OpenAI, Google, and Anthropic.
What it does: The organization claims that its hugegest Molmo model outcarry outs OpenAI’s GPT-4o in tests that meacertain slfinishergs enjoy benevolent images, charts, and records. Meanwhile, Ai2 says a petiteer Molmo model comes shut to OpenAI’s state-of-the-art model in carry outance, an achievement it ascribes to immensely more effective data assembleion and training methods.
English